Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharma-Bio ServPBSV -27.16%43 PB Ratio is 0.93 as of Aug. 02, 2026, which is 15% below its 10-year median of 1.09. GuruFocus rates PBSV with a GF Score™ of 43/100 and a GF Value™ of $0.58 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 608 Healthcare Providers & Services companies, Pharma-Bio Serv ranks better than 80.43% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-02), Pharma-Bio Serv's share price is $0.4225. Pharma-Bio Serv's Book Value per Share for the quarter that ended in Apr. 2026 was $0.46. Hence, Pharma-Bio Serv's PB Ratio of today is 0.93.
Good Sign:
Pharma-Bio Serv Inc stock PB Ratio (=0.93) is close to 1-year low of 0.89.
The historical rank and industry rank for Pharma-Bio Serv's PB Ratio or its related term are showing as below:
PBSV'
s PB Ratio Range Over the Past 10 Years
Min: 0.36 Med: 1.09 Max: 1.63
Current: 0.93
During the past 13 years, Pharma-Bio Serv's highest PB Ratio was 1.63. The lowest was 0.36. And the median was 1.09.
PBSV's PB Ratio is ranked better than 80.43% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 2.05
vs PBSV: 0.93
During the past 12 months, Pharma-Bio Serv's average Book Value Per Share Growth Rate was -13.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -10.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -11.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -5.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Pharma-Bio Serv was 218.00% per year. The lowest was -10.80% per year. And the median was 3.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Pharma-Bio Serv PB Ratio Related Terms
Pharma-Bio Serv PB Ratio Historical Data
* Premium members only.
The historical data trend for Pharma-Bio Serv's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Pharma-Bio Serv's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma-Bio Serv PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's PB Ratio distribution charts can be found below:
* The bar in red indicates where Pharma-Bio Serv's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Pharma-Bio Serv's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Pharma-Bio Serv (PBSV) has a PB Ratio of 0.93 as of Aug. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pharma-Bio Serv and its competitors. This is 15% below median its historical median of 1.09. Over the past decade, Pharma-Bio Serv's PB Ratio has ranged from 0.36 to 1.63. According to the industry distribution chart, Pharma-Bio Serv ranks #119 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 19.6%.
Is Pharma-Bio Serv's PB Ratio too high?
Pharma-Bio Serv's current PB Ratio of 0.93 is 15% below median its 10-year median of 1.09. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 1.63. The Healthcare Providers & Services industry median PB Ratio is 2.05. Pharma-Bio Serv's value of 0.93 is 54.6% below this industry median. Based on the distribution chart, Pharma-Bio Serv ranks #119 out of 608 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pharma-Bio Serv has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pharma-Bio Serv's PB Ratio compare to MGRX and BFRG?
According to the Healthcare Providers & Services industry distribution chart, Pharma-Bio Serv ranks #119 out of 608 companies for PB Ratio. This places Pharma-Bio Serv in the top 20% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.05. Pharma-Bio Serv's value of 0.93 is 54.6% below this benchmark. Historically, Pharma-Bio Serv's own PB Ratio has ranged from 0.36 to 1.63 over the past decade. While the company's 10-year median is 1.09 vs. the industry median of 2.05, Pharma-Bio Serv has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.05, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pharma-Bio Serv's current PB Ratio of 0.93 is 54.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pharma-Bio Serv and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharma-Bio Serv's current PB Ratio is 0.93, which is 15% below median its own 10-year median of 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharma-Bio Serv stock overvalued right now?
Based on GuruFocus' analysis, Pharma-Bio Serv (PBSV) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.58, compared to a current price of $0.42 — trading 27.2% below its estimated fair value. The current PB Ratio is 0.93, which is 15% below median its 10-year median of 1.09 and 54.6% below the Healthcare Providers & Services industry median of 2.05. Pharma-Bio Serv's overall GF Score™ is 43/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Pharma-Bio Serv (PBSV), the current PB Ratio is 0.93 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharma-Bio Serv (PBSV) Overvalued in 2026?
Based on GuruFocus' analysis, Pharma-Bio Serv stock appears to be undervalued.
The current stock price of $0.42 is trading 27.2% below its estimated GF Value™ of $0.58.
GuruFocus considers Pharma-Bio Serv to be Modestly Undervalued.
Key valuation signals for PBSV:
PB Ratio: 0.93 (15% below median its 10-year median of 1.09)
GF Value™: $0.58 vs. price of $0.42 (27.2% below fair value)
Industry Position: 54.6% below the Healthcare Providers & Services median (#119 of 608)
No single metric tells the full story. See the PBSV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies. It generates maximum revenue from Puerto Rico and also has its presence in United States, Europe and Other countries.
43GF Score
Get the complete analysis for PBSV
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PBSV has been successfully added to your 
